Differential Gene Expression and Activation of Signaling Pathways in Radioresistant and Radiosensitive Cancer Cell Lines

被引:0
作者
Glushchenko, E. S. [1 ]
Slesarvev, S. M. [2 ]
Moskovkin, A. A. [3 ]
Plotcev, V. M. [4 ]
Saenko, Y. V. [1 ]
机构
[1] Ulyanovsk State Univ, Res Technol Inst, Lab Mol & Cellular Biol, 42 L Tolstogo St, Ulyanovsk 432017, Russia
[2] Ulyanovsk State Univ, Dept Biol Ecol & Environm Sci, 42 L Tolstogo St, Ulyanovsk 432017, Russia
[3] Ulyanovsk State Univ, Dept Radiat Technol, Radiobiol Lab, 42 L Tolstogo St, Ulyanovsk 432017, Russia
[4] Ulyanovsk State Univ, Dept Radiat Technol, 42 L Tolstogo St, Ulyanovsk 432017, Russia
关键词
malignant tumors; gene expression; cancer cell radioresistance; radiation; OncoFinder method;
D O I
10.17691/stm2016.8.2.02
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The aim of the investigation was to study differential gene expression and signaling pathways activation in radioresistant and radiosensitive cancer cell lines. Materials and Methods. K562 radioresistant cancer cell line of chronic myeloleukosis, and HCT-116p53 (+/+), HCT-116p53 (-/-), Me45 radiosensitive cancer cell lines were used in the study. Transcriptome analysis was performed using Affymetrix DNA microarray HGU133A series. Original Gene Selector program was used for bioinformation analysis. Protein interaction networks were studied by means of online STRING 9.0 system. To range the genes according to the signaling pathways the PANTHER program and QIAGEN SABiosciences database were used. Quantitative activation of signaling pathways was calculated with the help of OncoFinder bioinformation algorithm. Results. Four genes (DAAM1, IFNAR2, PALLD, STK17A) were identified to increase their expression in radioresistant cell line and to decrease it in radiosensitive cell lines under radiation exposure. Three signal pathways - Wnt, Interferon and p53 - in which these genes are involved and which are common to the examined cell lines were found using PANTHER program. A significant difference in activation of these signaling pathways was discovered in radioresistant and radiosensitive cell lines. Conclusion. Based on the analysis of molecular interaction networks and signaling pathway activation it has been revealed that the greatest differences between radioresistant and radiosensitive cell lines are observed in the activity of Interferon and p53 signaling pathways. TP53 gene expression level is not associated with the activity of p53 signaling pathway. Comparison of gene expression changes and activation of signaling pathways allows us to suggest the expression of DAAM1, IFNAR2, PALLD genes as indicators of radioresistance under radiation exposure.
引用
收藏
页码:14 / 20
页数:7
相关论文
共 29 条
  • [1] Oncofinder, a new method for the analysis of intracellular signaling pathway activation using transcriptomic data
    Buzdin, Anton A.
    Zhavoronkov, Alex A.
    Korzinkin, Mikhail B.
    Venkova, Larisa S.
    Zenin, Alexander A.
    Smirnov, Philip Yu.
    Borisov, Nikolay M.
    [J]. FRONTIERS IN GENETICS, 2014, 5
  • [2] Enhancing the antitumor activity of ErbB blockade with histone deacetylase (HDAC) inhibition
    Chinnaiyan, P
    Varambally, S
    Tomlins, SA
    Ray, S
    Huang, SM
    Chinnaiyan, AM
    Harari, PM
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2006, 118 (04) : 1041 - 1050
  • [3] Radiotherapy and oral capecitabine in the preoperative treatment of patients with rectal cancer:: Rationale, preliminary results and perspectives
    Corvó, R
    Pastrone, I
    Scolaro, T
    Marcenaro, M
    Berretta, L
    Chiara, S
    [J]. TUMORI, 2003, 89 (04) : 361 - 367
  • [4] Pharmacological inhibition of EGFR tyrosine kinase affects ILK-mediated cellular radiosensitization in vitro
    Eke, Iris
    Sandfort, Veit
    Storch, Katja
    Baumann, Michael
    Roeper, Barbara
    Cordes, Nils
    [J]. INTERNATIONAL JOURNAL OF RADIATION BIOLOGY, 2007, 83 (11-12) : 793 - 802
  • [5] Phosphorylation of both EGFR and ErbB2 is a reliable predictor of prostate cancer cell proliferation in response to EGF
    El Sheikh, SS
    Domin, J
    Abel, P
    Stamp, G
    Lalani, EN
    [J]. NEOPLASIA, 2004, 6 (06): : 846 - 853
  • [6] STAT1 signaling is associated with acquired crossresistance to doxorubicin and radiation in myeloma cell lines
    Fryknas, Marten
    Dhar, Sumeer
    Oberg, Fredrik
    Rickardson, Linda
    Rydaker, Maria
    Goransson, Hanna
    Gustafsson, Mats
    Pettersson, Ulf
    Nygren, Peter
    Larsson, Rolf
    Isaksson, Anders
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2007, 120 (01) : 189 - 195
  • [7] Signalling via integrins: Implications for cell survival and anticancer strategies
    Hehlgans, Stephanie
    Haase, Michael
    Cordes, Nils
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2007, 1775 (01): : 163 - 180
  • [8] The role of IL-6 and STAT3 in inflammation and cancer
    Hodge, DR
    Hurt, EM
    Farrar, WL
    [J]. EUROPEAN JOURNAL OF CANCER, 2005, 41 (16) : 2502 - 2512
  • [9] Hussein MR, 2005, CANCER BIOL THER, V4, P57
  • [10] p53-related pathways and the molecular pathogenesis of melanoma
    Hussein, MR
    Haemel, AK
    Wood, GS
    [J]. EUROPEAN JOURNAL OF CANCER PREVENTION, 2003, 12 (02) : 93 - 100